Unique epitopes recognized by antibodies induced in Chikungunya virus-infected non-human primates: implications for the study of immunopathology and vaccine development.
about
Infectious Chikungunya Virus in the Saliva of Mice, Monkeys and HumansPrime-boost immunization strategies against Chikungunya virusNonhuman Primate Models of Chikungunya Virus Infection and Disease (CHIKV NHP Model)Animal Models of Chikungunya Virus Infection and Disease.Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques.Sero-prevalence and cross-reactivity of chikungunya virus specific anti-E2EP3 antibodies in arbovirus-infected patientsLoss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody responseIsolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus.Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus.Viral glycoproteins: biological role and application in diagnosis.Diagnostic potential of monoclonal antibodies against the capsid protein of chikungunya virus for detection of recent infection.Development of novel antibodies against non-structural proteins nsP1, nsP3 and nsP4 of chikungunya virus: potential use in basic research.Alphavirus capsid proteins self-assemble into core-like particles in insect cells: A promising platform for nanoparticle vaccine development.Chikungunya Virus in Macaques, Malaysia.Chikungunya Virus: Pathophysiology, Mechanism, and Modeling.Differing epidemiological dynamics of Chikungunya virus in the Americas during the 2014-2015 epidemic
P2860
Q24288650-6732961A-7F32-4DFA-8BDE-CB7722DB036FQ24701774-F170E9EB-69E7-4541-B617-122D4AFB69FBQ26782722-D09570BC-AE94-4A97-A7D7-BB8309B675B3Q30240216-A11CDF60-CBDE-4615-8F85-5DEE904C9004Q33853893-4E61574D-AF3B-42BE-A43F-E603D9A41BDBQ34875480-7F548613-7DA6-4503-98B2-38CAD84A92D6Q35023852-51B495FE-91CA-457F-9574-E97E8D8A192BQ35850197-CE6C3DE7-E8E6-4B7B-948A-2E96F0DA87A5Q37711813-93409798-EB59-4B77-91F4-704A533A5DF6Q38543883-5227C994-1335-4364-8634-0A15172A5F81Q40112455-B333DCF0-8B99-42E0-8809-A23B68D908EEQ40142933-8C3D5533-04F3-41C7-96A0-D1C44A5A72DAQ41045012-2B124DC7-8254-419C-8215-B7320606F36AQ42539696-0DFB0CF7-2B3B-4BA1-9397-2DD15C2217F5Q44843465-98168AA1-F4DA-4730-9ECA-19160F058088Q56762981-A7640DCD-BAFC-4659-897A-462B4FBCA18F
P2860
Unique epitopes recognized by antibodies induced in Chikungunya virus-infected non-human primates: implications for the study of immunopathology and vaccine development.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Unique epitopes recognized by ...... ology and vaccine development.
@ast
Unique epitopes recognized by ...... ology and vaccine development.
@en
type
label
Unique epitopes recognized by ...... ology and vaccine development.
@ast
Unique epitopes recognized by ...... ology and vaccine development.
@en
prefLabel
Unique epitopes recognized by ...... ology and vaccine development.
@ast
Unique epitopes recognized by ...... ology and vaccine development.
@en
P2093
P2860
P50
P1433
P1476
Unique epitopes recognized by ...... ology and vaccine development.
@en
P2093
Diane Simarmata
Hugues Tolou
Roger Le Grand
Wendy W L Lee
P2860
P304
P356
10.1371/JOURNAL.PONE.0095647
P407
P577
2014-04-22T00:00:00Z